Okeiro

Paris, France Founded: 2023 • Age: 3 yrs
Provider of AI-powered predictive analytics for transplant and chronic disease management

About Okeiro

Okeiro is a Healthcare company based in Paris (France) founded in 2023 by Pierrick Arnal and Alexandre Loupy. Okeiro has raised $10.98 million across 1 funding round from investors including Alven, Forepont Capital Partners and Red River West. Its chief executive, as recorded, is Pierrick Arnal. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Remote Monitoring.

Company details

Provider of AI-powered predictive analytics for transplant and chronic disease management. This platform uses predictive algorithms validated for clinical care and research to improve patient monitoring. It offers tools for healthcare professionals to anticipate clinical changes, enabling proactive interventions. Patients benefit from improved medical follow-up and enhanced communication with caregivers. Pharmaceutical companies can leverage the platform to accelerate clinical trials through faster evaluation of research results. The technology centralizes data, providing a clear, instant overview and intelligent alerts to detect early warning signs of complications. A dedicated nurse supports telehealth monitoring, freeing up clinicians time. The platform also facilitates research through virtualized clinical trials and the use of predictive models.

  • Headquarters Paris, France
  • Founders Pierrick Arnal, Alexandre Loupy
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website okeiro.com/en
  • Social LinkedIn
Key Metrics
  • Total Equity Funding
    $10.98M (USD)

    in 1 rounds

  • Latest Funding Round
    $10.98M (USD), Series A

    Apr 2025

  • Investors
    Alven

    & 2 more

Funding Insights of Okeiro

Okeiro has successfully raised a total of $10.98M through 1 strategic funding round. The most recent funding activity was a Series A round of $10.98 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $10.98M
  • Total Rounds 1
  • Last Round Series A β€” $10.98M
  • First Round $10.98M

    (Apr 2025)

  • Investors Count 3

All 1 funding rounds of Okeiro with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2025$10.98MSeries A–Alven, Forepont Capital Partners
–
Valuation history

3 investors in total: 3 institutional.

Investors in Okeiro

Okeiro has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Alven, Forepont Capital Partners and Red River West.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Early-stage investments are targeted by Alven, a venture capital firm.
alven.coParis, France
forepont.com
European tech companies are supported for U.S. market expansion.
redriverwest.com
Premium access

Investor details for Okeiro

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Okeiro

3 people are tracked at Okeiro (3 in leadership).

NameRoleGroup
Thierry Beaupere
Co-FondateurLeadership
Pierrick Arnal
Co-Founder & CEOLeadership
Alexandre Loupy
Co-FounderLeadership
Premium access

Complete people profiles for Okeiro

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Okeiro

2 dated milestones of Okeiro across 2 years, from founding to its latest funding, stage changes and deals.

  1. Founded Okeiro is founded.
  2. Funding First funding round of $11.0M.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Okeiro

Okeiro was founded in 2023 and raised its 1st funding round 2 years after it was founded.

Okeiro is headquartered in Paris, France.

Pierrick Arnal is the CEO of Okeiro, as recorded in our data. They have also founded this company.

Okeiro is a funded company, having raised a total of $10.98M across 1 funding round to date. The company's 1st funding round was a Series A of $10.98M, raised on Apr 2025.

Provider of AI-powered predictive analytics for transplant and chronic disease management. This platform uses predictive algorithms validated for clinical care and research to improve patient monitoring. It offers tools for healthcare professionals to anticipate clinical changes, enabling proactive interventions. Patients benefit from improved medical follow-up and enhanced communication with caregivers. Pharmaceutical companies can leverage the platform to accelerate clinical trials through faster evaluation of research results. The technology centralizes data, providing a clear, instant overview and intelligent alerts to detect early warning signs of complications. A dedicated nurse supports telehealth monitoring, freeing up clinicians time. The platform also facilitates research through virtualized clinical trials and the use of predictive models.

Okeiro has 3 investors. Key investors include Alven, Forepont Capital Partners, and Red River West.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available